Oruka Therapeutics, Inc. (ORKA) Stock Analysis

Oruka Therapeutics, Inc. (ORKA) is a publicly traded company in the HEALTHCARE sector. It trades at $55.23, carries a market capitalization of $3.53B. This page summarizes the public market data, fundamentals, and frequently asked questions for ORKA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $55.23
• Market Cap: $3.53B
• EPS: $-1.93
• 52-Week High: $91.00
• 52-Week Low: $10.77

Market Sentiment

Oruka Therapeutics, Inc. currently has a Bullish sentiment score of 0.22.

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. is a forward-thinking biotechnology company dedicated to advancing innovative therapies that address critical medical needs across a range of chronic and complex diseases. By harnessing state-of-the-art research and development resources, the firm is positioned to bring transformative treatment solutions to market. With a robust pipeline of promising product candidates and a steadfast commitment to scientific rigor, Oruka Therapeutics is well-equipped to drive meaning...

GNG Research Analysis

GNG Research scores Oruka Therapeutics, Inc. (ORKA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ORKA.

Frequently Asked Questions

Does ORKA pay dividends?

Oruka Therapeutics, Inc. (ORKA) does not currently pay a regular dividend.

What is ORKA's market cap?

Oruka Therapeutics, Inc. (ORKA) has a market capitalization of $3.53B with a current stock price of $55.23.